Company Registration No. 11930365 (England and Wales)
Sterling Pharma Limited
Unaudited accounts
for the year ended 30 April 2023
Sterling Pharma Limited
Unaudited accounts
Contents
Sterling Pharma Limited
Company Information
for the year ended 30 April 2023
Directors
Mohammed Eshak
Mohammed Ikhlaq
Mohammed Adam Issat
Asif Mahmood
Company Number
11930365 (England and Wales)
Registered Office
195-197 OTLEY ROAD
BRADFORD
WEST YORKSHIRE
BD3 0JF
UNITED KINGDOM
Sterling Pharma Limited
Statement of financial position
as at 30 April 2023
Tangible assets
2,102
1,799
Cash at bank and in hand
19,205
6,308
Creditors: amounts falling due within one year
(50,267)
(47,601)
Net current liabilities
(19,497)
(17,179)
Net liabilities
(17,395)
(15,380)
Called up share capital
100
100
Profit and loss account
(17,495)
(15,480)
Shareholders' funds
(17,395)
(15,380)
For the year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2023 and were signed on its behalf by
Mohammed Adam Issat
Director
Company Registration No. 11930365
Sterling Pharma Limited
Notes to the Accounts
for the year ended 30 April 2023
Sterling Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 11930365. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% straight line
4
Tangible fixed assets
Computer equipment
Amounts falling due within one year
Sterling Pharma Limited
Notes to the Accounts
for the year ended 30 April 2023
6
Creditors: amounts falling due within one year
2023
2022
Other creditors
32,000
32,000
Loans from directors
13,423
14,051
7
Average number of employees
During the year the average number of employees was 1 (2022: 1).